Framingham renewable energy company Ameresco announced Thursday a partnership with Wales-based Merthyr Tydfil Council, resulting in a $1.45-million energy conservation project.
Arch Therapeutics, a Framingham biotechnology company specializing in wound care and biosurgical devices, announced on Monday its AC5 Advanced Wound System would be added to federal contracts.
Retail parent company TJX Cos., headquartered in Framingham, will ask its U.S. office employees to work remotely for the last week of December and first week of January, the company confirmed Tuesday morning.
Clean energy company Ameresco, of Framingham, has completed a lighting project as part of an ongoing project relationship with Hazelwood School District in St. Louis County.
Framingham retail parent TJX Cos., Inc., one of the five largest employers in Central Massachusetts, will require booster shots for its vaccinated U.S. office workforce, the company confirmed Wednesday morning.
Framingham biotech company SCIEX announced a supply relationship with RedShiftBio, a Burlington firm specializing in analytical instrumentation for therapeutic drugs.
The TJX Cos. Inc., headquartered in Framingham, reported $1 billion in profits in the company's third quarter, according to an earnings report released Wednesday.
The 9/90 Corporate Center, a four-building office and lab campus in Framingham, sold for $93 million in a multi-property deal closed on Wednesday, Newmark Group, Inc., who brokered the deal, announced.